Skip to main content
. 1999 Jul 10;319(7202):87–90. doi: 10.1136/bmj.319.7202.87

Table 3.

Mean (SD) changes in inhaled corticosteroid dose (μg/day) during study

Treatment group Prestudy Pre-allocation Last tolerated % reduction from allocation
Placebo 1681 (670) 1079 (557) 727 (743) 30%
Montelukast 1588 (646)  976 (553) 526 (716) 47%*
*

P=0.046 compared with placebo.